Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0R2B stock hub

LON/0R2B has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R2Bis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

88.9B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R2B

In the news

Latest news · LON/0R2B

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.8

P25 12.9P50 16.9P75 23.5

Trailing P/E32

P25 15.9P50 22.9P75 35.8

ROE7.1

P25 -54.2P50 2.1P75 13.7

ROIC6.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R2B market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

232

Groups with data

Currency

USD

Showing 232 of 232 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	60,000
Employees Change	-3,000%
Employees Change Percent	-4.76
Enterprise value	$99.2B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US2358511028
Last refreshed	2026-05-10
Market cap	$88.9B
Price	$173
Price currency	USD
Rev Per Employee	316,011.89x
Sector	Healthcare
Sic	3826
Symbol	lon/0R2B
Website	https://www.danaher.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.12%
EV Earnings	35.73x
EV/EBIT	24.79x
EV/EBITDA	16.37x
EV/FCF	24.91x
EV/Sales	5.45x
FCF yield	4.48%
Forward P/E	19.82x
P/B ratio	2.23x
P/E ratio	32.03x
P/S ratio	4.77x
PE Ratio10 Y	33.82x
PE Ratio3 Y	39.43x
PE Ratio5 Y	36.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22%
EBITDA Margin	32.02%
FCF margin	21.35%
Gross margin	58.99%
Gross Profit	$11B
Gross Profit Growth	2.61%
Gross Profit Growth Q	1.84%
Gross Profit Growth3 Y	-1.18%
Gross Profit Growth5 Y	-0.36%
Net Income	$2.8B
Net Income Growth	-2.02%
Net Income Growth Q	7.86%
Net Income Growth Quarters	3%
Net Income Growth Years	0%
Net Income Growth3 Y	-18.63%
Net Income Growth5 Y	-4.3%
Pretax Margin	17.51%
Profit Margin	14.89%
Profit Per Employee	$47,049
Profitable Years	14
ROA	4.19
Roa5y	4.66
ROCE	7.17
ROE	7.08
Roe5y	9.78
ROIC	6.86
Roic5y	8.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-10.15%
Cagr3y	-6.3%
Cagr5y	-5.09%
Div CAGR3	10.06%
Div CAGR5	12.64%
EPS Growth	0.42
EPS Growth Q	9.85
EPS Growth Quarters	3
EPS Growth Years	0
EPS Growth3 Y	-17.7
EPS Growth5 Y	-4.05
FCF Growth	7.94%
FCF Growth Q	2.94%
FCF Growth3 Y	-10.43%
FCF Growth5 Y	-3.59%
OCF Growth	3.06%
OCF Growth Q	1.77%
OCF Growth10 Y	4.74%
OCF Growth3 Y	-8.83%
OCF Growth5 Y	-2.37%
Revenue Growth	4.02x
Revenue Growth Q	3.66x
Revenue Growth Quarters	4x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.17x
Revenue Growth5 Y	-0.02x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.3
Assets	$62.9B
Cash	$4.3B
Current Assets	$10.2B
Current Liabilities	$5.5B
Debt	$14.8B
Debt EBITDA	$2.38
Debt Equity	$0.37
Debt FCF	$3.72
Equity	$39.8B
Interest Coverage	21.3
Liabilities	$23B
Long Term Assets	$52.6B
Long Term Liabilities	$17.5B
Net Cash	$-10.5B
Net Cash By Market Cap	$-11.84
Net Debt EBITDA	$1.76
Net Debt Equity	$0.26
Net Debt FCF	$2.64
Tangible Book Value	$-5.3B
Tangible Book Value Per Share	$-7.42
WACC	7.77

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.87
Inventory Turnover	3.95
Net Working Capital	$1.3B
Quick ratio	1.4
Working Capital	$4.9B
Working Capital Turnover	$3.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	2.27%
Dividend Growth	20.35%
Dividend Growth Years	10%
Dividend per share	$1.01
Dividend Years	11
Dividend Yield	0.58%
Ex Div Date	2026-03-27
Last Dividend	$0.4
Payout Frequency	Quarterly
Payout Ratio	24.67%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-10.14%
200-day SMA	208.2
3Y total return	-17.74%
50-day SMA	189.7
50-day SMA vs 200-day SMA	50under200
5Y total return	-22.97%
All Time High	333.6
All Time High Change	-48.17%
All Time High Date	2021-09-10
All Time Low	93.26
All Time Low Change	85.41%
All Time Low Date	2018-02-09
ATR	7
Beta	0.84
Ch YTD	-24.95
High	179.2
High52	244.5
High52 Date	2026-01-22
High52ch	-29.28%
Low	171.3
Low52	171.3
Low52 Date	2026-05-08
Low52ch	0.96%
Ma50ch	-8.87%
Price vs 200-day SMA	-16.96%
RSI	32.21
RSI Monthly	35.03
RSI Weekly	33.35
Sharpe ratio	-0.36x
Sortino ratio	-0.32
Total Return	2.85%
Tr YTD	-24.79
Tr1m	-9.09%
Tr1w	-1.73%
Tr3m	-20.12%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$4.1B
Operating Income Growth	5.86
Operating Income Growth Q	5.73
Operating Income Growth3 Y	-7.65
Operating Income Growth5 Y	-2.42
Operating margin	22

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	630,660,388%
Net Borrowing	992,444,442
Shares Insiders	10.79%
Shares Institutions	84.41%
Shares Qo Q	0.03%
Shares Yo Y	-2.27%
Short Ratio	1.84

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$3.8B
Average Volume	2,165.9x
Bv Per Share	56.3
CAPEX	$-863.8M
Ch1m	-9.09
Ch1w	-1.73
Ch1y	-10.76
Ch3m	-20.29
Ch3y	-28.23
Ch5y	-33.26
Ch6m	-17.26
Change	-0.89%
Change From Open	-3.5
Close	174.5
Days Gap	2.71
Depreciation Amortization	1,821,315,262
Dollar Volume	373,312.7
Earnings Date	2026-04-21
EBIT	$4.1B
EBITDA	$6B
EPS	$3.9
F Score	6
FCF	$4B
FCF EV Yield	4.01x
Financing CF	-1,249,100,200
Fiscal Year End	December
Founded	1,969
Goodwill	31,368,726,210
Graham Number	97.02792
Graham Upside	-43.89
Income Tax	$499.6M
Investing CF	-905,221,410
Is Primary Listing	0
Last Earnings Date	2026-04-21
Last Report Date	2026-03-27
Lynch Fair Value	$26.99
Lynch Upside	-84.39
Ma150	211.1
Ma150ch	-18.09%
Ma20	183.6
Ma20ch	-5.83%
Net CF	2,790,158,760
Open	179.2
P FCF Ratio	22.33
P OCF Ratio	18.35
Payment Date	2026-04-24
Position In Range	20.91
Ppne	4,891,071,352
Price Date	2026-05-08
Price EBITDA	$14.89
Relative Volume	1.1x
Revenue	18,644,701,660x
SBC By Revenue	1.19x
Share Based Comp	221,978,650
Tax By Revenue	2.68x
Tax Rate	15.3%
Tr6m	-16.96%
Volume	2,159
Z Score	4.29

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R2B dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.6%

$1.01 annual per share

Payout ratio

+24.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+12.6%

10 consecutive years of growth

Total shareholder yield

+2.8%

Next ex-dividend date: 2026-03-27

Performance

LON/0R2B stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R2B?

Insider, institutional, and short-interest positioning.

Institutional ownership

+84.4%

Share of float held by funds and institutions

Insider ownership

+10.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R2B momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.2

Neutral momentum band

Price vs 200-day MA

-17.0%

50/200-day relationship not available

Beta (5Y)

0.84

Moves roughly with the market

Sharpe ratio

-0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R2B

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R2B stock rating?

lon/0R2B is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R2B analysis?

The full report lives at /stocks/lon/0R2B/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R2B?

The latest report frames lon/0R2B around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R2B page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.